155
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Clinical and Molecular Epidemiologic Characteristics of Ceftazidime/Avibactam-Resistant Carbapenem-Resistant Klebsiella pneumoniae in a Neonatal Intensive Care Unit in China

, , , , &
Pages 2571-2578 | Published online: 27 Jul 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Zejuan Ji, Keming Sun, Zhenwei Li, Weyland Cheng & Junwen Yang. (2021) Carbapenem-Resistant Klebsiella pneumoniae Osteomyelitis Treated with Ceftazidime-Avibactam in an Infant: A Case Report. Infection and Drug Resistance 14, pages 3109-3113.
Read now
Ziyan Kong, Xuemei Liu, Chenxi Li, Siyun Cheng, Fei Xu & Bing Gu. (2020) Clinical Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Among Pediatric Patients in Jiangsu Province, China. Infection and Drug Resistance 13, pages 4627-4635.
Read now

Articles from other publishers (5)

Anne L. McCartney & Lesley Hoyles. (2023) The role of Klebsiella populations in preterm infants . Biochemical Society Transactions 51:2, pages 887-896.
Crossref
Sushma Krishna, Neha Mishra, NikhilNediyan Chath, Gowrishankar Swamy & ShrikanthKanchana Pala. (2022) Newer drug for the resistant bug: A case report of spondylodiscitis with Klebsiella pneumoniae producing carbapenemase managed successfully with ceftazidime-avibactam. Journal of Orthopaedic Association of South Indian States 19:1, pages 36.
Crossref
Jie Fang, Hui Li, Min Zhang, Guochao Shi, Mengying Liu, Yujie Wang & Xiaolan Bian. (2021) Efficacy of Ceftazidime-Avibactam Versus Polymyxin B and Risk Factors Affecting Clinical Outcomes in Patients With Carbapenem-Resistant Klebsiella pneumoniae Infections a Retrospective Study. Frontiers in Pharmacology 12.
Crossref
Wenli Liao, Na Huang, Ying Zhang, Yao Sun, Tao Chen, Weiliang Zeng, Liqiong Chen, Hong Wen, Jianming Cao & Tieli Zhou. (2021) Comparison of Carbapenem-Resistant Klebsiella pneumoniae Strains Causing Intestinal Colonization and Extraintestinal Infections: Clinical, Virulence, and Molecular Epidemiological Characteristics. Frontiers in Public Health 9.
Crossref
Natália Kehl Moreira & Juliana Caierão. (2021) Ceftazidime-avibactam: are we safe from class A carbapenemase producers’ infections?. Folia Microbiologica 66:6, pages 879-896.
Crossref